Alfuzosin Sandoz 10 mg
Alfuzosin Sandoz 10 mg is a medicine authorised by Swissmedic under authorisation number 57442. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 February 2006 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 57442 |
|---|---|
| Name | Alfuzosin Sandoz 10 mg |
| Full name | Alfuzosin Sandoz 10 mg, Retardtabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 02 February 2006 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Alfuzosin Sandoz 10 mg, Retardtabletten | B | 02 February 2006 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Alfuzosin Sandoz 10 mg authorised in Switzerland?
Yes. Alfuzosin Sandoz 10 mg is authorised by Swissmedic under authorisation number 57442, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Alfuzosin Sandoz 10 mg have?
Alfuzosin Sandoz 10 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Alfuzosin Sandoz 10 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.